NFL Biosciences
Develops botanical drug candidates to treat smoking and alcohol addictions.
ALNFL | PA
Overview
Corporate Details
- ISIN(s):
- FR0014003XO1 (+1 more)
- LEI:
- 9695006VJWNTN4UNHA27
- Country:
- France
- Address:
- 199 RUE HELENE BOUCHER, 34170 CASTELNAU-LE-LEZ
- Website:
- https://www.nflbiosciences.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
NFL Biosciences is a biopharmaceutical company that develops botanical drug candidates for the treatment of addictions. The company's lead asset is NFL-101, an innovative drug candidate for smoking cessation derived from a nicotine-free protein extract of tobacco leaves. Its pipeline also includes NFL-301, a candidate aimed at reducing excessive alcohol consumption. NFL Biosciences operates with an outsourced research model, focusing on advancing its products through preclinical and clinical studies. The company's primary business strategy is to license its developed drug candidates to larger pharmaceutical companies for final commercialization.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-21 08:00 |
NFL BIOSCIENCES: POSITIVE FDA RESPONSE FOLLOWING THE PRE-IND APPLICATION FOR NF…
|
English | 420.8 KB | ||
| 2024-05-15 17:45 |
NFL Biosciences : Assemblée générale mixte du 30 mai 2024
|
French | 209.3 KB | ||
| 2024-04-18 08:00 |
NFL Biosciences further strengthens its operational team with the arrival of a …
|
English | 456.1 KB | ||
| 2024-04-18 08:00 |
NFL Biosciences renforce son équipe opérationnelle avec l’arrivée d’une Respons…
|
French | 529.6 KB | ||
| 2024-04-12 07:45 |
Successful capital increase for NFL Biosciences with over €3 million raised
|
English | 245.6 KB | ||
| 2024-04-12 07:45 |
Succès de l’opération de NFL Biosciences avec plus de 3 millions d’euros levés …
|
French | 1.4 MB | ||
| 2024-04-11 17:45 |
NFL Biosciences launches a fundraising round for 3 million euros through a capi…
|
English | 161.2 KB | ||
| 2024-04-11 17:45 |
NFL Biosciences lance une levée de fonds d’environ 3 millions d’euros par voie …
|
French | 169.2 KB | ||
| 2024-04-02 08:00 |
NFL BIOSCIENCES SHOWCASES THE RESULTS OF ITS STUDIES TO THE SCIENTIFIC AND PHAR…
|
English | 276.0 KB | ||
| 2024-04-02 08:00 |
NFL BIOSCIENCES VALORISE SES RÉSULTATS D’ÉTUDES AUPRÈS DE LA COMMUNAUTÉ SCIENTI…
|
French | 333.1 KB | ||
| 2024-03-29 17:45 |
NFL BIOSCIENCES: 2023 FULL-YEAR BUSINESS AND EARNINGS UPDATE
|
English | 1.1 MB | ||
| 2024-03-29 17:45 |
NFL BIOSCIENCES : ACTIVITÉS & RÉSULTATS ANNUELS 2023
|
French | 1.3 MB | ||
| 2024-02-13 17:45 |
NFL BIOSCIENCES PRÉSENTERA LES RÉSULTATS DE L’ÉTUDE PRECESTO LORS DU CONGRÈS DE…
|
French | 92.9 KB | ||
| 2024-02-13 17:45 |
NFL BIOSCIENCES WILL PRESENT THE RESULTS OF THE PRECESTO CLINICAL STUDY AT THE …
|
English | 77.3 KB | ||
| 2024-01-30 08:00 |
NFL BIOSCIENCES: SUCCESS OF THE STUDY WITH THE CEA
|
English | 734.3 KB |
Automate Your Workflow. Get a real-time feed of all NFL Biosciences filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NFL Biosciences
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NFL Biosciences via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
